Skip to main content
. 2008 Dec 23;23(6):929–936. doi: 10.3346/jkms.2008.23.6.929

Table 2.

Seroprotection rates after primary vaccination

graphic file with name jkms-23-929-i002.jpg

*, Those who were immunized with a PRP-OMP; †, compared PRP-T with PRP-OMP after 2 doses, p<0.05; ‡, compared PRP-T with PRP-OMP 1 month after primary series, p<0.05.

PRP-T, polyribosylribitol phosphate-tetanus toxoid conjugate; PRP-OMP, polyribosylribitol phosphate-meningococcal outer membrane protein conjugate; N, number of subjects in the according-to-protocol cohort for immunogenicity with available results; 95% CI, 95% confidence interval; mo, month.